Suppr超能文献

恶二唑曼尼希碱:合成与抗分枝杆菌活性

Oxadiazole mannich bases: synthesis and antimycobacterial activity.

作者信息

Ali Mohamed Ashraf, Shaharyar Mohammad

机构信息

Department of Medicinal Chemistry, Alwar Pharmacy College, Alwar, Rajasthan 301030, India.

出版信息

Bioorg Med Chem Lett. 2007 Jun 15;17(12):3314-6. doi: 10.1016/j.bmcl.2007.04.004. Epub 2007 Apr 6.

Abstract

A series of oxadiazole mannich bases were synthesized by reacting oxadiazole derivatives, dapsone and appropriate aldehyde in the presence of methanol. The synthesized compounds were evaluated for antimycobacterial activity against M. tuberculosis H(37)Rv and INH resistant M. tuberculosis. Among the synthesized compounds, compound (4) 3-{2-furyl[4-(4-{2-furyl[5-(2-naphthyloxymethyl)-2-thioxo-2,3-dihydro-1,3,4-oxadiazol-3-yl]methylamino}phenylsulfonyl)anilino]methyl}-5-(2-naphthyloxymethyl)-2,3-dihydro-1,3,4-oxadiazole-2-thione was found to be the most promising compound active against M. tuberculosis H(37)Rv and isoniazid (INH) resistant M. tuberculosis with Minimum inhibitory concentration (MIC) 0.1 microM & 1.10 microM respectively.

摘要

通过使恶二唑衍生物、氨苯砜和适当的醛在甲醇存在下反应,合成了一系列恶二唑曼尼希碱。对合成的化合物进行了抗结核分枝杆菌活性评估,针对结核分枝杆菌H(37)Rv和耐异烟肼的结核分枝杆菌。在合成的化合物中,化合物(4) 3-{2-呋喃基[4-(4-{2-呋喃基[5-(2-萘氧基甲基)-2-硫代-2,3-二氢-1,3,4-恶二唑-3-基]甲基氨基}苯基磺酰基)苯胺基]甲基}-5-(2-萘氧基甲基)-2,3-二氢-1,3,4-恶二唑-2-硫酮被发现是最有前景的化合物,对结核分枝杆菌H(37)Rv和耐异烟肼(INH)的结核分枝杆菌具有活性,最低抑菌浓度(MIC)分别为0.1微摩尔和1.10微摩尔。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验